Abdel-Latif MK, Abd El-Mageed HR, Mohamed HS, Mustafa FM (2019) Study the solvation effect on 6-phenyl-2-thioxo-1,2-dihydropyridine-3-carbonitrile derivatives by TD- DFT calculations and molecular dynamics simulations. J Mol Struct 1200:127056
Article
Google Scholar
Abdulkareem I (2013) Aetio-pathogenesis of breast cancer. Nig Med J 54(6):371
Article
Google Scholar
Ahmed SA, Ahmed OM, Elgendy HS (2014) Novel synthesis of puriensanalougues and thieno[2,3-b] pyridine derivatives with anticancer and antioxidant activity. J Pharm Res 8(9):1303–1313
CAS
Google Scholar
Chauhan HP, Sapana J, Jaswant C (2016) Mixed bismuth(III) complexes with sulfur donor ligands Studies on synthetic, structural, thermal and biological properties. J Therm Anal Calorim 124:117–130
Article
CAS
Google Scholar
Cheang MCU, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14(5):1368–1376
Article
CAS
PubMed
Google Scholar
Crown J (2017) CDK8: a new breast cancer target. Oncotarget 8(9):14269–14270
Article
PubMed
PubMed Central
Google Scholar
Dirar AI, Waddad AY, Mohamed MA, Mohamed MS, Osman WJ, Mohammed MS, Elbadawi MAA, Hamdoun S (2016) In silico pharmacokinetics and molecular docking of three leads isolated from Tarconanthus camphorates. Int J Pharm Sci 8(5):8
Google Scholar
Du J, Sun H, Xi L, Li J, Yang Y, Liu H, Yao X (2011) Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM–GBSA calculation. J Comput Chem 32(13):2800–2809
Article
CAS
PubMed
Google Scholar
Godet I, Gilkes DM (2017) BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integ Cancer Sci Therap 4(1)
Goske M, Ramachander VRV, Komaravalli PL, Rahman PF, Rao C, Jahan P (2017) CTLA-4 Genetic Variants (rs11571317 and rs3087243): Role in susceptibility and progression of breast cancer. World J Oncol 8(5):162–170
Article
CAS
PubMed
PubMed Central
Google Scholar
Halgren TA (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Info Mod 49(2):377–389
Article
CAS
Google Scholar
Haupt S, Vijayakumaran R, Miranda PJ, Burgess A, Lim E, Haupt Y (2017) The role of MDM2 and MDM4 in breast cancer development and prevention. J Mol Cell Bio 9(1):53–61
Article
CAS
Google Scholar
Hayakawa I, Shioya R, Agatsuma T, Furukawa H, Naruto S, Sugano Y (2004) A library synthesis of 4-hydroxy-3-methyl-6-phenylbenzofuran-2-carboxylic acid ethyl ester derivatives as anti-tumor agents. Bioorg Med Chem Lett 14(17):4383–4387
Article
CAS
PubMed
Google Scholar
Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LAG, Cronin KA (2014) US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 106(5)
Irminger-Finger I, Ratajska M, Pilyugin M (2016) New concepts on BARD1: regulator of BRCA pathways and beyond. Inter J Biochem Cell Bio 72:1–17
Article
CAS
Google Scholar
Juric D, Rodon J, Tabernero J, Janku F, Burris HA, Schellens JHM, Middleton MR, Berlin J, Schuler M, Gil-Martin M, Rugo HS, Seggewiss-Bernhardt R (2018) Phosphatidylinositol 3-kinase α–selective inhibition with alpelisib (BYL719) in PIK3CA - altered solid tumors: results from the first-in-human study. J Clin Oncol 36(13):1291–1299
Article
CAS
PubMed
PubMed Central
Google Scholar
Kaarthigeyan K (2012) Cervical cancer in India and HPV vaccination. Ind J Med Paedi Oncol 33(1):7
Article
CAS
Google Scholar
Khan RT, Siddique A, Shahid N, Khokher S, Fatima W (2018) Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan. Breast Can 25(3):350–355
Article
Google Scholar
Kumbar SS, Hosamani KM, Shettar AK, Joshi D (2017) Environmentally benign synthesis, computational investigation, and mechanistic studies of novel coumarincarbonodithioate frameworks as anticancer drugs: an approach to microwave synthesis. Eur J Pharm Med Sci 4(11):389–400
Google Scholar
Lei H, Deng C-X (2017) Fibroblast growth factor receptor 2 signaling in breast cancer. Int J Biol Sci 13(9):1163–1171
Article
CAS
PubMed
PubMed Central
Google Scholar
Levacque Z, Rosales JL, Lee K-Y (2012) Level of cdk5 expression predicts the survival of relapsed multiple myeloma patients. Cell Cycle 11(21):4093–4095
Article
CAS
PubMed
PubMed Central
Google Scholar
Li J, Li M, Chen P, Ba Q (2018) High expression of PALB2 predicts poor prognosis in patients with advanced breast cancer. FEBS Open Bio 8(1):56–63
Article
CAS
PubMed
Google Scholar
Link PA, Baer MR, James SR, Jones DA, Karpf AR (2008) p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia. Cancer Res 68(22):9358–9366
Article
CAS
PubMed
PubMed Central
Google Scholar
Lose F, Lovelock P, Chenevix-Trench G, Mann GJ, Pupo GM, Spurdle AB (2006) Variation in the RAD51 gene and familial breast cancer. Breast Cancer Res 8(3)
Ma X-J, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang BM, Zhou Y-X, Varnholt H et al (2003) Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci 100(10):5974–5979
Article
CAS
PubMed
PubMed Central
Google Scholar
Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comp Aided Mol Des 27(3):221–234
Article
CAS
Google Scholar
Mangasuli SN, Hosamani KM, Satapute P, Joshi SD (2018) Synthesis, molecular docking studies and biological evaluation of potent coumarin–carbonodithioate hybrids via microwave irradiation. Chem Data Colle 15(16):115–125
Article
Google Scholar
Mohamed HSH, Ahmed SA (2019) Reviewing of synthesis and computational studies of pyrazolo pyrimidine derivatives. J Chem Rev 1(3):154–251
Google Scholar
Moitessier N, Englebienne P, Lee D, Lawandi J, Corbeil CR (2009) Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go: Docking/scoring methods-a review. Br J Pharm 153(S1):S7–S26
Article
Google Scholar
Musa M, Cooperwood J, Khan MO (2008) A review of coumarin derivatives in pharmacotherapy of breast cancer. Curr Med Chem 15(26):2664–2679
Article
CAS
PubMed
PubMed Central
Google Scholar
Paplomata E, O’Regan R (2014) The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers. Ther Adv Med Onco 6(4):154–166
Article
CAS
Google Scholar
Pernas S, Tolaney SM, Winer EP, Goel S (2018) CDK4/6 inhibition in breast cancer: current practice and future directions. Ther Adv Med Oncol 10:1–15
Article
Google Scholar
Pierce AC, Jacobs M, Stuver-Moody C (2008) Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase. J Med Chem 51(6):1972–1975
Article
CAS
PubMed
Google Scholar
Qin H, Liu L, Sun S, Zhang D, Sheng J, Li B, Yang W (2018) The impact of PI3K inhibitors on breast cancer cell and its tumour microenvironment. Peer J 6:5092
Article
Google Scholar
Riggio M, Perrone MC, Polo ML, Rodriguez MJ, May M, Abba M, Lanari C, Novaro V (2017) AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins. Sci Rep 7:44244
Article
CAS
PubMed
PubMed Central
Google Scholar
Rosales JL, Lee K-Y (2006) Extraneuronal roles of cyclin-dependent kinase 5. BioEssay 28(10):1023–1034
Article
CAS
Google Scholar
Salam NK, Huang TH-W, Kota BP, Kim MS, Li Y, Hibbs DE (2007) Novel PPARgamma agonists identified from a natural product library: a virtual screening, induced-fit docking and biological assay study: novel PPAR-γ agonists from natural products. Chem Bio Drug Des 71(1):57–70
Article
Google Scholar
Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE (2009) Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Ame J Epide 169(10):1251–1259
Article
Google Scholar
Tabana YM, Hassan LEA, Ahamed MBK, Dahham SS, Iqbal MA, Saeed MAA, Khan MSS, Sandai D, Majid ASA, Oon CE, Majid AMSA (2016) Scopoletin, an active principle of tree tobacco (Nicotiana glauca) inhibits human tumor vascularization in xenograft models and modulates ERK1, VEGF-A, and FGF-2 in computer model. Microvasc Res 107:17–33
Article
CAS
PubMed
Google Scholar
Thorpe LM, Yuzugullu H, Zhao JJ (2015) PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer 15(1):7–24
Article
CAS
PubMed
PubMed Central
Google Scholar
US Food and Drug Administration. https://www.fda.gov/drugs/resources-informationapproveddrugs/fda-approves-alpelisib-metastatic-breast-cancer. Accessed 28 May 2019
Wang R, Cao X-J, Kulej K, Liu W, Ma T, MacDonald M, Chiang C-M, Garcia BA, You J (2017) Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma. Proc Nat Acad Sci 114(27):5352–E5361
Article
Google Scholar
Yamane K, Tateishi K, Klose RJ, Fang J, Fabrizio LA, Erdjument-Bromage H, Taylor-Papadimitriou J, Tempst P, Zhang Y (2007) PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 25(6):801–812
Article
CAS
PubMed
Google Scholar
Zhou Y, Zhao W, Xie G, Huang M, Hu M, Jiang X, Zeng D, Liu J, Zhou H, Chen H (2014) Carcinogenesis 35(12):2660–2669
Article
CAS
PubMed
PubMed Central
Google Scholar